Document is current

Article History

Received: 6 November 2023

Revised: 6 November 2023

Accepted: 14 December 2023

First Online: 10 January 2024

Declarations

:

: The authors declare no competing interests.

: AD: No conflicts of interest to disclose; KB: No conflicts of interest to disclose; CI: No conflicts of interest to disclose; CO: No conflicts of interest to disclose; OE: No conflicts of interest to disclose; YC: No conflicts of interest to disclose; MS: No conflicts of interest to disclose; TZ: No conflicts of interest to disclose; ST: Honoraria for serving on advisory board at AbbVie, Beiersdorf, Inc., EPI Health, Evolus, Inc., Galderma Laboratories, L.P., Hugel, L’Oreal USA Inc., Medscape, Scientis, UCB, Vichy Laboratories, Avita Medical; Honoraria as a consultant for Arcutis, Inc., Beiersdorf, Inc., Cara Therapeutics, Johnson & Johnson Consumer Products Company, Regeneron, Dior, Bristol Myers Squibb; Honoraria for serving on board of directors for Mercer Strategies, PA, LLC; Fees for serving as employee of Mercer Strategies, PA, LLC; Honoraria as a speaker/faculty education for Beiersdorf, Inc., L’Oreal USA Inc., Medscape, MJH Life Sciences; Stock options as a consultant for Armis Biopharma, Inc., Piction Health; Stock/stock options for serving on advisory board at Biorez, Inc., GloGetter, Inc.; Grants/research funding as investigator for Croma-Pharma GmbH Austria, Eli Lilly and Company, Pfizer, Inc., Concert Pharmaceuticals; NN: Honoraria for serving on advisory board at Helsinn Healthcare, Kyowa Kirin; Grants/research funding for serving as investigator for Helsinn Healthcare.